A growing body of evidence indicates that lower plasma levels of EETs, frequently due to increased soluble epoxide hydrolase (sEH) activity, are linked with conditions such as hypertension, coronary artery disease, and endothelial dysfunction [5,6]. The gene discussed is EPHX2; the disease is coronary artery disorder.